ACRES Commercial Realty Corp. ACR
ACRES Commercial Realty Corp. (ACR) functions as a real estate investment trust (REIT) based in Uniondale, New York, having been established in 2005. The firm's primary objective is to generate, own, and administer various debt instruments related to commercial real estate, including mortgage loans, throughout the United States. ACR strategically allocates capital to a diverse range of assets tied to commercial properties. These investments encompass both variable and fixed-rate first lien mortgage loans, senior and junior participations in first mortgage loans, mezzanine financing, preferred equity investments, commercial mortgage-backed securities (CMBS), and direct equity or preferred equity stakes in commercial real estate. As a certified REIT for federal income tax purposes, the company typically avoids federal corporate income tax, contingent on distributing 100% of its taxable REIT income. Notably, the entity updated its legal name to ACRES Commercial Realty Corp. in February 2021, having previously been known as Exantas Capital Corp.
This overview is background from company filings and may not reflect the latest quarter — the figures above are the current data, and the SEC filings are the primary source.
Plain-English: the Snapshot is the quick read — what it pays you (yield, dividend), how its cash flow looks (FFO/AFFO, Price/OCF) and how much debt it carries. Switch to Expert in the header to hide these explanations.
Snapshot
Reported FFO / EAD / leverage are from the Q1 2026 earnings release (filed 2026-04-30) — 8-K, EX-99.1 ✓ Verified to filing.
Yield uses the latest declared dividend, annualized (latest regular payout × frequency; special/liquidating distributions excluded) — an announced-but-not-yet-declared change isn't reflected until it has an ex-date. FFO, AFFO and Net debt / Adj. EBITDA are the company's reported figures from its latest earnings 8-K. Price/OCF and payout use GAAP operating cash flow. NAV premium and credit ratings have no free source yet. See Methodology.
$10,000 invested
Illustrative income only, at today's price and latest declared dividend — it excludes price changes, dividend cuts and taxes. Not a forecast.
Model ACR yourself — any amount, shares, per-payment & a multi-year DRIP projection →
Balance sheet (latest FY: 2025)
Debt-maturity ladder, fixed/floating split, secured/unsecured and coverage ratios come from the supplemental — not yet ingested.
Financial history
| FY | Revenue | Net income | D&A | EBITDA | Op. cash flow |
|---|---|---|---|---|---|
| 2025 | $165.90M | $21.32M | $10.25M | $124.09M | $4.10M |
| 2024 | $83.49M | $29.27M | $9.69M | $135.78M | $19.39M |
| 2023 | $91.13M | $22.39M | $5.19M | $155.06M | $45.61M |
| 2022 | $62.88M | $10.62M | $7.49M | $95.85M | $32.70M |
| 2021 | $106.43M | $33.92M | $13.99M | $115.82M | $40.59M |
| 2020 | $-80.86M | $-197.71M | $6.52M | $-136.79M | $31.81M |
Dividends
Recent regular dividends per share (special distributions excluded), oldest → newest.
| Ex-date | Record | Payment | Declared | Amount | Freq. |
|---|---|---|---|---|---|
| 2019-12-30 | 2019-12-31 | 2020-01-28 | 2019-12-11 | $0.28 | Quarterly |
| 2019-09-27 | 2019-09-30 | 2019-10-25 | 2019-09-12 | $0.25 | Quarterly |
| 2019-06-27 | 2019-06-28 | 2019-07-26 | 2019-06-12 | $0.23 | Quarterly |
| 2019-03-28 | 2019-03-29 | 2019-04-26 | 2019-03-15 | $0.20 | Quarterly |
| 2018-12-28 | 2018-12-31 | 2019-01-25 | 2018-12-12 | $0.17 | Quarterly |
| 2018-09-27 | 2018-09-28 | 2018-10-26 | 2018-09-13 | $0.15 | Quarterly |
| 2018-06-28 | 2018-06-29 | 2018-07-27 | 2018-06-15 | $0.10 | Quarterly |
| 2018-03-28 | 2018-03-30 | 2018-04-27 | 2018-03-21 | $0.05 | Quarterly |
| 2017-12-28 | 2017-12-29 | 2018-01-26 | 2017-12-19 | $0.05 | Quarterly |
| 2017-09-28 | 2017-09-29 | 2017-10-27 | 2017-09-19 | $0.05 | Quarterly |
| 2017-06-28 | 2017-06-30 | 2017-07-28 | 2017-06-19 | $0.05 | Quarterly |
| 2017-03-29 | 2017-03-31 | 2017-04-27 | 2017-03-20 | $0.05 | Quarterly |
| 2016-12-28 | 2016-12-30 | 2017-01-27 | 2016-12-15 | $0.05 | Quarterly |
| 2016-09-28 | 2016-09-30 | 2016-10-28 | 2016-09-19 | $0.42 | Quarterly |
| 2016-06-28 | 2016-06-30 | 2016-07-28 | 2016-06-16 | $0.42 | Quarterly |
| 2016-03-29 | 2016-03-31 | 2016-04-28 | 2016-03-17 | $0.42 | Quarterly |
| 2015-12-29 | 2015-12-31 | 2016-01-28 | 2015-12-14 | $0.42 | Quarterly |
| 2015-09-28 | 2015-09-30 | 2015-10-28 | 2015-09-17 | $0.64 | Quarterly |
| 2015-06-26 | 2015-06-30 | 2015-07-28 | 2015-06-19 | $0.16 | Quarterly |
| 2015-03-27 | 2015-03-31 | 2015-04-28 | 2015-03-20 | $0.16 | Quarterly |
| 2014-12-29 | 2014-12-31 | 2015-01-28 | 2014-12-18 | $0.20 | Quarterly |
| 2014-09-26 | 2014-09-30 | 2014-10-28 | 2014-09-19 | $0.20 | Quarterly |
| 2014-06-26 | 2014-06-30 | 2014-07-28 | 2014-06-18 | $0.20 | Quarterly |
| 2014-03-27 | 2014-03-31 | 2014-04-28 | 2014-03-20 | $0.20 | Quarterly |
Coverage (payout of operating cash flow): 198.79%. Tax-character split (ordinary / 199A / capital gain / return of capital) — not disclosed (requires the annual allocation release).
Recent news — ACR
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
ACRES Commercial (ACR) Moves 9.5% Higher: Will This Strength Last?
ACRES Commercial Realty Corp. Reauthorizes an Additional $5 Million Share Repurchase Program
ACRES Commercial Realty Corp (ACR) Stock Down 4.4% -- Now Undervalued? GF Score: 57/100
TiVo Ads Launches Enhanced U.S. TV Viewership Data Offering, Unifying STB and ACR Data in a Single Feed
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
Headlines via Financial Modeling Prep; links open the original publisher in a new tab. Not an endorsement or investment advice.
Other Mortgage REITs
Same-store NOI, occupancy, leasing/WALT, top tenants, external-manager fees, development pipeline and (for non-traded vehicles) share-class fees, redemption/gating and NAV methodology are planned modules sourced from supplementals and prospectuses.